The current news topics relating to PGD and the baby born without the breast cancer gene reflects some of the work I generated during my RCA design interactions degree 2005-2007.
In particular the P-Evo Clinic:
The Personal Evolution Clinic was a scenario generated during the FORESIGHT internship I was involved in during 2006. The P-Evo Clinic is the ultimate preventative measure against our obesity epidemic. P-EVO is a development of the Family Planning Association. It offers services to would-be parents, through DNA and genomic screening, to predict genetic variants in the not-yet-conceived child. Parents can prepare for possible special requirements their unborn child may need in an obesogenic environment. The experience of a visit to the P-EVO clinic is a rare blend of religious vision, health spa and theatrical spectacle.
The Gene Ceremony from the FATE INSTITUTE is a ritualistic experience that focuses on the implications of predictive gene testing on our future health susceptibility. A variety of foods act as DNA swabs to determine the likelihood of developing certain diseases or behavioural disorders. The ceremonial process ensures the experience of extracting the individuals genetic material is in line with the severity of the diagnostic information it reveals. The DNA material extracted from the jelly bone will be used by the FATE INSTITUTE to test each participant for their susceptibility to contracting Alzheimers or breast cancer in the future. The diagnosis is one part of a custom made course of future therapy provided at the holisitic institute of the Futures Association for Therapy and Entertainment.
PGD news links
The first baby in the UK tested before conception for a genetic form of breast cancer has been born. Doctors at University College London said the girl and her mother were doing well following the birth this week.The embryo was screened for the altered BRCA1 gene, which would have meant the girl had a 80% chance of developing breast cancer. link
Genetic tests that can detect a raised risk of breast, ovarian and prostate cancer are being offered for the first time to people without family histories of the diseases, The Times has learnt. The programme, run by University College London (UCL), paves the way for a new approach to preventive medicine involving widespread screening. It will also prompt greater demand for screening of embryos by parents who carry a defective gene and want to avoid passing it to their children. News of the programme came as Paul Serhal, medical director at University College Hospital’s Assisted Conception Unit, announced the birth of one of the world’s first babies selected to be free of a genetic risk of breast cancer. link
The birth of the first British baby genetically screened before conception to be free of a breast cancer gene was hailed yesterday as a breakthrough by doctors but raised fresh questions about the ethics of creating so-called designer babies. The baby girl grew from an embryo screened to ensure that it did not contain the faulty BRCA1 gene, which would have meant she had a 50%-85% of developing breast cancer. link